Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2010
07/01/2010WO2010075270A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
07/01/2010WO2010075269A1 Pyrimidine derivatives as gpcr modttlators for use in the treatment of obesity and diabetes
07/01/2010WO2010075127A1 Antiviral compounds
07/01/2010WO2010075074A1 Protein kinase inhibitors
07/01/2010WO2010074607A2 Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
07/01/2010WO2010074326A1 Probe for a biological specimen and labelling method and screening method using the probe
07/01/2010WO2010074244A1 Isoquinoline derivative
07/01/2010WO2010074193A1 Novel bicyclic heterocyclic compound
07/01/2010WO2010074090A1 Crystals of hydrochloride of pyridazin-3(2h)-one compound and process for production of same
07/01/2010WO2010073235A1 Ppar agonist compositions and methods of use
07/01/2010WO2010073128A2 Fused imidazole derivatives as trpv3 antagonist
07/01/2010WO2010073034A1 Pyrimidine indole derivatives for treating cancer
07/01/2010WO2010072781A2 Imine compounds for combating invertebrate pests
07/01/2010WO2010072759A1 Process for the preparation of esomeprazole
07/01/2010WO2010072680A1 Crystalline form of an organic compound
07/01/2010WO2010072607A1 Dihydropyridone amides as p2x7 modulators
07/01/2010WO2010072599A1 Dihydropyridone ureas as p2x7 modulators
07/01/2010WO2010072597A1 Dihydropyridone amides as p2x7 modulators
07/01/2010WO2010036329A3 Process for making quinolone compounds
07/01/2010WO2010033977A3 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
07/01/2010WO2010030983A3 Pyrazole carboxamide inhibitors of factor xa
07/01/2010WO2010025138A3 Pyrimidine compounds
07/01/2010WO2010003974A3 Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
07/01/2010WO2009070645A8 Indoles, derivatives, and analogs thereof and uses thereof
07/01/2010US20100168433 Process for preparing bepotastine and intermediates used therein
07/01/2010US20100168431 Novel isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
07/01/2010US20100168429 Transition metal catalyzed synthesis of N-aminoindoles
07/01/2010US20100168421 A new peptide deformylase inhibitor compound and manufacturing process thereof
07/01/2010US20100168420 Taxol Derivatives With Antitumor Activity
07/01/2010US20100168419 Diacylglycerol Acyltransferase Inhibitors
07/01/2010US20100168418 Novel nitrogenated heterocyclic compound and salt thereof
07/01/2010US20100168417 2-Indolyl Imidazo [4,5-d] Phenanthroline Derivatives and Their Use in the Treatment for Cancer
07/01/2010US20100168416 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
07/01/2010US20100168189 Therapeutic substituted lactams
07/01/2010US20100168182 Compounds and compositions as kinase inhibitors
07/01/2010US20100168181 Benzimidazole amido derivatives, their manufacture and use as pharmaceutical agents
07/01/2010US20100168175 Atpenins
07/01/2010US20100168173 Heterocycles substituted pyridine derivatives and antifungal agent containing thereof
07/01/2010US20100168168 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands
07/01/2010US20100168167 Piperidinones Useful in the Treatment of Inflammation
07/01/2010US20100168164 Antidiabetic Oxazolidinediones and Thiazolidinediones
07/01/2010US20100168163 Cyclic-alkylamine derivatives as inhibitors of the interaction between mdm2 and p53
07/01/2010US20100168162 Selective inhibitors of akt and methods of using same
07/01/2010US20100168160 Genipin Derivatives and Uses Thereof
07/01/2010US20100168156 Novel Benzoxathiine Derivative
07/01/2010US20100168143 Quinazoline derivatives
07/01/2010US20100168134 Pyridyl piperidine orexin receptor antagonists
07/01/2010US20100168132 Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
07/01/2010US20100168131 Novel compounds
07/01/2010US20100168125 Indolizines and aza-analog derivatives thereof as cns active compounds
07/01/2010US20100168124 Novel heterocyclic substituted pyridine compounds with cxcr3 antagonist activity
07/01/2010US20100168123 Akt protein kinase inhibitors
07/01/2010US20100168107 Imidazole compounds for the treatment of neurodegenerative disorders
07/01/2010US20100168106 Amino-5-(5-membered)heteroarylimidazolone Compounds And The Use Thereof For Beta-secretase Modulation
07/01/2010US20100168105 Spirocyclopropyl Piperidine Derivatives
07/01/2010US20100168104 Hiv inhibiting 5-amido substituted pyrimidines
07/01/2010US20100168103 Diaryl piperidine compounds as calcium channel blockers
07/01/2010US20100168101 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
07/01/2010US20100168100 Quinoline derivatives as p13 kinase inhibitors
07/01/2010US20100168099 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions
07/01/2010US20100168096 Acylguanidine derivative or salt thereof
07/01/2010US20100168093 Substituted 3-amino-4 -hydroxy pyrrolidines compounds, their preparation and use as medicaments
07/01/2010US20100168088 Pyrrolidine derivatives as nk-3 receptor antagonists
07/01/2010US20100168083 Adamantane derivatives for the treatment of the metabolic syndrome
07/01/2010US20100168077 Novel Pyridine Derivatives, Processes for Preparing Them, Pharmaceutical Compositions Thereof
07/01/2010US20100168076 Diphenyl substituted alkanes
07/01/2010US20100168070 Compounds for the treatment of alzheimer's disease
07/01/2010US20100168066 Novel insecticides
07/01/2010US20100168065 Quinolinone derivatives as parp and tank inhibitors
07/01/2010US20100168063 Bicyclic pyrimidinones and uses thereof
07/01/2010US20100168062 Quinoxaline Derivatives as Tyrosine Kinase Activity Inhibitors
07/01/2010US20100168060 Salts of benzimidazolyl pyridyl ethers and formulations thereof
07/01/2010US20100166881 Novel IDO Inhibitors and Methods of Use Thereof
07/01/2010US20100166839 Non peptidic renin inhibitors nitroderivatives
07/01/2010US20100166819 Transforming Growth Factor Modulators
07/01/2010US20100166765 Benzoquinazoline derivatives
07/01/2010US20100166706 Hcv ns-3 serine protease inhibitors
07/01/2010US20100166655 1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
07/01/2010CA2750841A1 Pyrimidine indole derivatives for treating cancer
07/01/2010CA2748251A1 Novel bicyclic heterocyclic compound
07/01/2010CA2748124A1 Ppar agonist compositions and methods of use
07/01/2010CA2747809A1 Bicyclic heterocycle derivatives and methods of use thereof
07/01/2010CA2747807A1 Pyrimidine derivatives and methods of use thereof
07/01/2010CA2747795A1 Isoquinoline derivative
07/01/2010CA2747784A1 Pharmaceutical compounds
07/01/2010CA2747055A1 Substituted benzimidazole derivatives as protein kinase inhibitors
07/01/2010CA2746834A1 Antiviral compounds
07/01/2010CA2746616A1 Imine compounds for combating invertebrate pests
07/01/2010CA2745952A1 Dihydropyridone amides as p2x7 modulators
07/01/2010CA2745866A1 Dihydropyridone ureas as p2x7 modulators
07/01/2010CA2745864A1 Dihydropyridone amides as p2x7 modulators
07/01/2010CA2744911A1 Fused imidazole derivatives as trpv3 antagonist
06/2010
06/30/2010EP2202231A1 2,3-dihydroiminoisoindole derivative
06/30/2010EP2202228A1 Amide compounds and use of the same
06/30/2010EP2201952A1 Omeprazole dosage forms and their use
06/30/2010EP2201002A1 5-ht7 receptor antagonists
06/30/2010EP2201001A1 Novel imidazole derivatives
06/30/2010EP2201000A1 Novel imidazole derivatives
06/30/2010EP2200998A1 Azacyclylisoquinolinone and isoindolinone derivatives as histamine-3 antagonists
06/30/2010EP2200990A1 Gamma secretase modulators